New York bills · 2025 Regular Session
New York A 7920
Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Matthew Slater (Republican/Conservative)
Cosponsors (4)
- Angelo J. Morinello (Republican)
- Robert Smullen (Republican)
- David McDonough (Republican)
- Keith Brown (Republican/Conservative/Independence)
Summary
Official abstract published by the New York legislature
Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 7, 2026 · House
REFERRED TO INSURANCE - Apr 11, 2025 · House
REFERRED TO INSURANCE